ASYMCHEM(06821.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 520.46 million, YoY decrease of 15.71%

NewTimeSpace (newtimespace.com) News, August 24, 2026, ASYMCHEM(06821.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 3.61 billion, increased by 13.13% YoY; Net Profit stood at CNY 514.11 million, YoY decrease of 16.15%; Profit Attributable to Shareholders stood at CNY 520.46 million, YoY decrease of 15.71%; Basic Earnings Per Share (EPS) stood at CNY 1.45.
In terms of profitability, ASYMCHEM Gross Profit changed from CNY 1.38 billion in the same period last year to CNY 1.51 billion in the current period, increased by CNY 135.21 million; gross profit margin changed from 43.26% in the same period last year to 41.99% in the current period, decreased by 1.27 percentage points; net profit changed from CNY 613.15 million in the same period last year to CNY 514.11 million in the current period, decreased by CNY 99.04 million; net profit margin changed from 19.23% in the same period last year to 14.25% in the current period, decreased by 4.98 percentage points.
In terms of earnings quality, ASYMCHEM Operating Profit changed from CNY 709.05 million in the same period last year to CNY 593.41 million in the current period, decreased by CNY 115.65 million; Operating Profit Margin changed from 22.24% in the same period last year to 16.45% in the current period, decreased by 5.79 percentage points.
In terms of financial soundness, ASYMCHEM Debt-to-Asset Ratio changed from 13.88% in the same period last year to 14.81% in the current period, increased by 0.93 percentage points; Total Equity changed from CNY 17.096 billion in the same period last year to CNY 17.746 billion in the current period, increased by CNY 649.73 million; Current Liabilities changed from CNY 2.08 billion in the same period last year to CNY 2.38 billion in the current period, increased by CNY 303.39 million; Quick Ratio changed from 4.98 in the same period last year to 3.76 in the current period, decreased by 1.22 percentage points.
In terms of R&D investment focus, ASYMCHEM R&D Expenses changed from CNY 285.75 million in the same period last year to CNY 251.88 million in the current period, decreased by CNY 33.87 million; R&D to Total Revenue Ratio changed from 8.96% in the same period last year to 6.98% in the current period, decreased by 1.98 percentage points.
By the close of trading on August 24, 2026, ASYMCHEM(06821) saw a loss of 7.26% in its share price, closing at HKD 111.1 and touched an intraday low of HKD 109.4. The full-day turnover stood at HKD 194.41 million, with the latest market capitalization at HKD 3.09 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.